Baylin et al. (2006) also demonstrated that DNA methyltransferase inhibitors triggered viral defense and induced IRF3 to translocate to the nucleus and activated transcription of IFNβ1 to influence immune signaling in cancers (Chiappinelli et al., 2015). The gene discussed is IFNB1; the disease is cancer.